| Diversity and Career in Medicine | Lifetime | 2 | US 2 | 99.82 |
| Advances in Oncology and Radiotherapy | Lifetime | 2 | US 2 | 99.69 |
| Breast Implant and Reconstruction | Lifetime | 15 | US 13 | 99.56 |
| Economic and Financial Impacts of Cancer | Lifetime | 19 | US 14 | 99.54 |
| Health and Medical Research Impacts | Lifetime | 12 | US 4 | 99.21 |
| Breast Cancer Treatment Studies | Lifetime | 69 | US 39 | 99.74 |
| Medical Education and Admissions | Lifetime | 11 | US 5 | 99.58 |
| COVID-19 and healthcare impacts | Lifetime | 117 | US 42 | 97.79 |
| Global Health Workforce Issues | Lifetime | 73 | US 34 | 98.27 |
| Global Cancer Incidence and Screening | Lifetime | 170 | US 91 | 98.93 |
| Breast Lesions and Carcinomas | Lifetime | 132 | US 76 | 98.80 |
| Innovations in Medical Education | Lifetime | 244 | US 98 | 98.19 |
| Advanced Radiotherapy Techniques | Lifetime | 310 | US 150 | 98.73 |
| Radiation Dose and Imaging | Lifetime | 285 | US 146 | 98.25 |
| Healthcare professionals’ stress and burnout | Lifetime | 128 | US 56 | 98.22 |
| Patient-Provider Communication in Healthcare | Lifetime | 151 | US 66 | 98.09 |
| BRCA gene mutations in cancer | Lifetime | 250 | US 139 | 98.12 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 828 | US 377 | 98.18 |
| Cancer survivorship and care | Lifetime | 404 | US 199 | 97.48 |
| Mentoring and Academic Development | Lifetime | 41 | US 36 | 96.75 |
| Multiple and Secondary Primary Cancers | Lifetime | 288 | US 125 | 97.08 |
| Sex and Gender in Healthcare | Lifetime | 45 | US 33 | 96.11 |
| Workplace Violence and Bullying | Lifetime | 100 | US 42 | 96.27 |
| Hospital Admissions and Outcomes | Lifetime | 122 | US 87 | 95.35 |
| Healthcare cost, quality, practices | Lifetime | 399 | US 220 | 95.17 |
| Ethics in Clinical Research | Lifetime | 552 | US 308 | 92.89 |
| Radiology practices and education | Lifetime | 501 | US 317 | 93.46 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 632 | US 277 | 90.24 |
| Pharmaceutical Economics and Policy | Lifetime | 976 | US 399 | 91.16 |
| Social Media in Health Education | Lifetime | 402 | US 219 | 89.79 |
| Pharmaceutical industry and healthcare | Lifetime | 420 | US 252 | 88.51 |
| Biomedical Ethics and Regulation | Lifetime | 797 | US 374 | 86.26 |
| Sexual Assault and Victimization Studies | Lifetime | 954 | US 625 | 83.03 |
| Healthcare Operations and Scheduling Optimization | Lifetime | 767 | US 296 | 75.61 |
| Healthcare Systems and Challenges | Lifetime | 512 | US 84 | 72.69 |
| Academic Publishing and Open Access | Lifetime | 650 | US 185 | 56.63 |
| Advances in Oncology and Radiotherapy | 2021-2025 | 2 | US 2 | 99.40 |
| Diversity and Career in Medicine | 2021-2025 | 4 | US 4 | 99.78 |
| Breast Cancer Treatment Studies | 2021-2025 | 35 | US 15 | 99.48 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 26 | US 17 | 98.48 |
| Medical Education and Admissions | 2021-2025 | 12 | US 11 | 97.77 |
| Global Health Workforce Issues | 2021-2025 | 40 | US 10 | 96.55 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 302 | US 98 | 97.00 |
| Health and Medical Research Impacts | 2021-2025 | 29 | US 14 | 94.51 |
| Healthcare professionals’ stress and burnout | 2021-2025 | 120 | US 33 | 95.60 |
| Workplace Violence and Bullying | 2021-2025 | 20 | US 3 | 94.14 |
| COVID-19 and healthcare impacts | 2021-2025 | 549 | US 179 | 92.49 |
| Breast Implant and Reconstruction | 2021-2025 | 99 | US 49 | 94.80 |
| Global Cancer Incidence and Screening | 2021-2025 | 298 | US 117 | 94.79 |
| Cancer survivorship and care | 2021-2025 | 319 | US 123 | 94.11 |
| Breast Lesions and Carcinomas | 2021-2025 | 132 | US 37 | 93.64 |
| Sex and Gender in Healthcare | 2021-2025 | 41 | US 19 | 90.28 |
| Cancer Treatment and Pharmacology | 2021-2025 | 715 | US 246 | 87.36 |
| Cancer Risks and Factors | 2021-2025 | 371 | US 137 | 85.93 |
| Innovations in Medical Education | 2021-2025 | 995 | US 397 | 85.52 |
| Management of metastatic bone disease | 2021-2025 | 661 | US 216 | 75.97 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 628 | US 222 | 73.51 |
| Mentoring and Academic Development | 2021-2025 | 104 | US 82 | 73.01 |
| Radiology practices and education | 2021-2025 | 580 | US 246 | 74.95 |
| Healthcare cost, quality, practices | 2021-2025 | 899 | US 383 | 70.11 |
| Pharmaceutical Economics and Policy | 2021-2025 | 920 | US 296 | 71.13 |
| Effects of Radiation Exposure | 2021-2025 | 874 | US 254 | 63.54 |
| Sexual Assault and Victimization Studies | 2021-2025 | 948 | US 423 | 48.68 |
